Detalhe da pesquisa
1.
Generation of human ILC3 from allogeneic and autologous CD34+ hematopoietic progenitors toward adoptive transfer.
Cytotherapy
; 26(2): 136-144, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38149947
2.
Engineering of CD34+ progenitor-derived natural killer cells with higher-affinity CD16a for enhanced antibody-dependent cellular cytotoxicity.
Cytotherapy
; 26(3): 252-260, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127030
3.
Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT).
Cytotherapy
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416085
4.
Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo.
Cell Mol Life Sci
; 80(10): 298, 2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728691
5.
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.
Cancer Immunol Immunother
; 70(11): 3167-3181, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796917
6.
CXCR4, but not CXCR3, drives CD8+ T-cell entry into and migration through the murine bone marrow.
Eur J Immunol
; 49(4): 576-589, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30707456
7.
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells.
Cancer Immunol Immunother
; 69(11): 2259-2273, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504246
8.
Decitabine enhances targeting of AML cells by CD34+ progenitor-derived NK cells in NOD/SCID/IL2Rgnull mice.
Blood
; 131(2): 202-214, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29138222
9.
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings.
Cytotherapy
; 22(7): 388-397, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414635
10.
Harnessing natural killer cells for the treatment of ovarian cancer.
Gynecol Oncol
; 157(3): 810-816, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268953
11.
Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(4): 712-719, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30399420
12.
Comprehensive Phenotyping of T Cells Using Flow Cytometry.
Cytometry A
; 95(6): 647-654, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714682
13.
Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(4): 666-677, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29197680
14.
Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.
Br J Haematol
; 181(1): 38-53, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318591
15.
CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
J Immunol
; 197(7): 2715-25, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27566820
16.
Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses.
Biol Blood Marrow Transplant
; 22(6): 1000-1008, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26860635
17.
The magnitude of cytokine production by stimulated CD56+ cells is associated with early stages of systemic sclerosis.
Clin Immunol
; 173: 76-80, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27616458
18.
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
Blood
; 124(23): 3490-500, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336630
19.
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
Cancer Immunol Immunother
; 64(5): 645-54, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25724840
20.
Umbilical cord blood-derived cellular products for cancer immunotherapy.
Cytotherapy
; 17(6): 739-748, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795272